Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 24, Number 35, 2017

Articles

Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
pp. 3829-3850(22)
Authors: Wojcik, Marzena; Krawczyk, Michal; Wojcik, Pawel; Cypryk, Katarzyna; Wozniak, Lucyna A.

Favourites:
ADD

Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders
pp. 3851-3878(28)
Authors: Sanchez-Barcelo, Emilio J.; Rueda, Noemi; Mediavilla, MarĂ­a D.; Martinez-Cue, Carmen; Reiter, Russel J.

Favourites:
ADD

Cadmium, Organ Toxicity and Therapeutic Approaches: A Review on Brain, Kidney and Testis Damage
pp. 3879-3893(15)
Authors: Rinaldi, Mariagrazia; Micali, Antonio; Marini, Herbert; Adamo, Elena B.; Puzzolo, Domenico; Pisani, Antonina; Trichilo, Vincenzo; Altavilla, Domenica; Squadrito, Francesco; Minutoli, Letteria

Favourites:
ADD

Open Access A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase
pp. 3894-3906(13)
Authors: Ahmad, Zulfiqar; Hassan, Sherif S.; Azim, Sofiya

Favourites:
ADD

Open Access Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development
pp. 3907-3920(14)
Authors: Samoylova, Tatiana I.; Braden, Timothy D.; Spencer, Jennifer A.; Bartol, Frank F.

Favourites:
ADD

Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects
pp. 3921-3937(17)
Authors: Cao, Hua; Wang, Kai; Ye, Yang-Liang; Shen, Jian-Hua

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content